Canopy Growth Corporation

AI Score

0

Unlock

2.22
-0.17 (-7.11%)
At close: Jan 14, 2025, 3:59 PM
2.23
0.45%
Pre-market Jan 15, 2025, 05:06 AM EST
undefined%
Bid 2.24
Market Cap 277.36M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -4.93
PE Ratio (ttm) -0.45
Forward PE n/a
Analyst Sell
Ask 2.28
Volume 7,213,097
Avg. Volume (20D) 6,135,898
Open 2.40
Previous Close 2.39
Day's Range 2.19 - 2.40
52-Week Range 2.19 - 14.92
Beta undefined

About CGC

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products ...

Sector Healthcare
IPO Date Apr 7, 2014
Employees 1,029
Stock Exchange NASDAQ
Ticker Symbol CGC

Analyst Forecast

According to 1 analyst ratings, the average rating for CGC stock is "Sell." The 12-month stock price forecast is $2, which is a decrease of -9.91% from the latest price.

Buy 0.00%
Hold 0.00%
Sell 100.00%
Stock Forecasts

Next Earnings Release

Canopy Growth Corporation is scheduled to release its earnings on Feb 7, 2025, before market opens.
Analysts project revenue of $69.55M, reflecting a 5.10% YoY growth and earnings per share of -0.31, making a -84.80% decrease YoY.
2 months ago · Source
-6.81%
Canopy Growth shares are trading lower. The compan... Unlock content with Pro Subscription
2 months ago · Source
-21.11%
Shares of cannabis stocks are trading lower after a cannabis legalization initiative did not pass in Florida.